作者:Rosalina Wisastra、Massimo Ghizzoni、André Boltjes、Hidde J. Haisma、Frank J. Dekker
DOI:10.1016/j.bmc.2012.06.019
日期:2012.8
responses. Selective inhibitors may provide a new therapeutic approach for inflammatory diseases. In this study, we describe the identification of a novel soybean lipoxygenase-1 (SLO-1) inhibitor and a potato 5-lipoxygenase (5-LOX) activator from a screening of a focused compound collection around the natural product anacardic acid. The natural product anacardic acid inhibits SLO-1 with an IC50 of
脂加氧酶催化不饱和脂肪酸的氧化,例如亚油酸,它们在炎症反应中起关键作用。选择性抑制剂可能为炎症性疾病提供一种新的治疗方法。在这项研究中,我们描述了一种新型的大豆脂氧合酶1(SLO-1)抑制剂和马铃薯5-脂氧合酶(5-LOX)活化剂的鉴定,该筛查是通过围绕天然产物无心果酸的集中化合物的筛选进行的。天然产物熊果酸抑制SLO-1的IC 50为52μM,而新型混合型抑制剂23的抑制能力提高了五倍。此外,另一种导数(21)引起了马铃薯5-LOX的不必要的激活。这表明存在调节脂肪氧化酶活性的变构结合位点。